Skip to main content
Premium Trial:

Request an Annual Quote

MWG to Sack 60 Percent of Staff as Revenue Declines; Restructuring Gains Steam

NEW YORK, Oct. 25 (GenomeWeb News) - MWG Biotech will slash around 60 percent of its workforce in a further effort to reduce costs, the company said today.


The move comes just weeks after MWG said it would sell its microarray and lab-automation businesses in order to focus on genomic synthesis, synthetic nucleic acids, oligonucleotide production, and DNA sequencing.


According to MWG, it will "massively reduce its workforce" from 351 to 140 "amid a streamlining of administration and sales structures." The company noted that "service for all international customers remains unaffected."


MWG announced the layoffs along with a drop in revenues for the first nine months of 2004, which fell to to 26.5 million ($33.9 million) from €32.6 million the year before. The company said its DNA sequencing and nucleic acids product businesses contributed €17.9 million in revenues during the first nine months of this year, while the microarrays and lab automation operations generated €8.5 million.


For the first nine months of 2004, MWG posted €6.8 million in losses before interest, taxes, depreciation, and amortization.


MWG said that for the full-year 2004, it anticipates revenues to total €31 million, with a loss before interest, taxes, depreciation, amortization, and restructuring costs of €9.4 million.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.